Condition
Hematopoietic Cell Transplantation (HCT)
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
Early P 1 (1)
P 1 (2)
Trial Status
Active Not Recruiting1
Withdrawn1
Not Yet Recruiting1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07302776Phase 1Not Yet Recruiting
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
NCT06679530Not ApplicableActive Not RecruitingPrimary
Music During Allogeneic Stem Cell Transplant Hospitalization
NCT07104799Phase 1Recruiting
Momelotinib During and After HCT in Myelofibrosis
NCT05951153Early Phase 1WithdrawnPrimary
Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell Transplantation
Showing all 4 trials